EP3185957
PATISIRAN FOR USE IN TREATING TRANSTHYRETIN MEDIATED AMYLOIDOSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.8.2015EP published:
1.6.2022EP application number:
15835924.0
EPO information:
European Patent Register
Max expiry date:
26.8.2035
Title in English:
PATISIRAN FOR USE IN TREATING TRANSTHYRETIN MEDIATED AMYLOIDOSISLanguage of the patent:
English
Timeline
Today
27.8.2015EP application
1.6.2022EP Publication
Owner
Name:
Alnylam Pharmaceuticals, Inc.Address:
300 Third Street, Cambridge, MA 02142, US
Inventor
Name:
BETTENCOURT, BrianAddress:
Cambridge, MA 02142, US
Priority
Number:
201462044100 PDate:
29.8.2014Country:
US
Number:
201562150596 PDate:
21.4.2015Country:
US
Classification
Categories:
A61K 31/573, A61K 31/495, A61K 31/41, A61K 31/341, A61K 31/435, A61P 9/00, A61P 25/02, A61P 25/28